Humacyte Announces New U.S. Department of Defense Funding for Procurement of Bioengineered Blood Vessels
DURHAM, N.C., Feb. 09, 2026 (GLOBE NEWSWIRE) -- Humacyte, Inc. (Nasdaq: HUMA), a commercial-stage biotechnology platform company developing universally implantable,...